Filter posts

Posts from the 9th Annual BIO Winhover & Pharmaceutical Strategic Outlook Conference (Feb 2010)

Did you miss a panel at the BIO Windhover/PSO Conference in New York? Here are …

VC Fundraising Back to 2005 Levels

Is Venture Capital “holding up” for US biotech? Although there is a silver lining that …

Posts from the 12th Annual BIO CEO & Investor Conference in New York (Feb 2010)

I created a new page on the blog (now called the “CONFERENCES” tab) where key …

BTK – A Decade of Change

Do you ever wonder what is really behind the often quoted BTK index (“NYSE Arca …

Many Biotechs Still Operating at Low Cash Levels

The percentage of public biotech companies that still operate with less than a year of …

Fewer Public Biotechs in 2010 vs 2008

Back in January 2008, we were tracking 394 “active” public biotech companies. (By “active”, we …

Sector Performance Since the 2007 Market Peak

How does the biotech sector performance rank against the 10 S&P sectors since the S&P500 …

Risk/Reward Favored Small & Micro Caps in 2009

For US biotechs in 2009, the smaller the company’s market capitalization, the higher the return…

2009 - A Big Year for the BTK

The Amex Biotech Index, the BTK, outpaced its peer, the Nasdaq Biotech Index, by 29% …

Small Biotechs Spending Less

The median and mean operational cash spending for small public US biotechs (less than 250 …